Nurix Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $568k | 62k | 9.24 |
| 2024-06-30 | $1.3M | 62k | 20.87 |
| 2024-03-31 | $3.5M | 237k | 14.70 |
| 2023-12-31 | $1.9M | 185k | 10.32 |
| 2023-09-30 | $1.4M | 184k | 7.86 |
| 2023-06-30 | $1.3M | 131k | 9.99 |
| 2023-03-31 | $116k | 13k | 8.88 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management